Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.47 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PREP | P48147 | 2/20 | 0.46 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.44 |
| ▸ | RECQL | P46063 | 1/20 | 0.44 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30862413 | 1.00 | MEN1 (0.56) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL190483 | 1.00 | MEN1 (0.56) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL1068107 | 1.00 | MEN1 (0.56) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| Water SCHEMBL28231929 | 0.98 | MEN1 (0.58) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| Water SCHEMBL28231930 | 0.98 | MEN1 (0.58) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| Ammonia Solution, Strong SCHEMBL28243999 | 0.98 | MEN1 (0.55) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL24438917 | 0.95 | HPGD (0.56) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL22439376 | 0.95 | HPGD (0.56) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| SCHEMBL2820898 | 0.95 | HPGD (0.56) | MEN1ALDH1A1MAPTKMT2AHPGD | |
| Alcohol SCHEMBL4274896 | 0.94 | MEN1 (0.54) | MEN1ALDH1A1MAPTKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 740 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118791425-A | Synthesis method of 1-BOC-3-piperidone and similar cyclic ketone compounds thereof | 浙江尚科生物医药有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118272334-A | Carbonyl reductase mutant and application thereof in synthesis of (R) -N-Boc-3-hydroxy piperidine | 西南大学 | 2024-07-02 | — | — | CN | claimed |
| EP-3115358-A1 | METHOD OF PREPARATION AND CHIRAL INVERSION OF CHIRAL-1-T-BUTOXYCARBONYL-3-HYDROXY PIPERIDINE | ABA Chemicals Corporation (CN) | 2017-01-11 | — | — | EP | claimed |
| CN-106188062-A | Replace the preparation method of Buddhist nun according to Shandong, replace intermediate and the preparation method of intermediate of Buddhist nun according to Shandong | 苏州鹏旭医药科技有限公司 | 2016-12-07 | — | — | CN | claimed |
| CN-103864673-B | The method of the preparation of chirality-1-tertbutyloxycarbonyl-3-hydroxy piperidine and chirality upset | ABA CHEMICALS CORPORATION (CN) | 2016-03-23 | — | — | CN | claimed |
| CN-103864673-A | Preparation of chirality-1-t-butyloxycarboryl-3-hydroxy piperidine and method for chirality turning | ABA CHEMICALS CORP | 2014-06-18 | — | — | CN | claimed |
| US-8697711-B2 | Inhibitors of bruton'S tyrosine kinase | PHARMACYCLICS, INC. (US) | 2014-04-15 | — | — | US | claimed |
| CN-103571908-A | Method for preparing chiral N-tert-butyloxycarboryl-3-hydroxypiperidine | SYNCOZYMES SHANGHAI CO LTD | 2014-02-12 | — | — | CN | claimed |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | LG CHEM, LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | LG CHEM, LTD. (KR) | 2026-05-19 | — | — | US | disclosed |
| US-12630562-B2 | Piperidylurea compounds and methods of use thereof | ARCUS BIOSCIENCES, INC. (US) | 2026-05-19 | — | — | US | disclosed |
| WO-2026098672-A1 | BIAZACYCLOALKANE MENIN-MLL PROTEIN INHIBITORS, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | 赛诺哈勃药业（成都）有限公司 | 2026-05-15 | — | — | WO | disclosed |
| CN-122010910-A | Biazacycloalkane Menin-MLL protein inhibitor, pharmaceutical composition and application thereof | 赛诺哈勃药业（成都）有限公司 | 2026-05-12 | — | — | CN | disclosed |
| US-20260103461-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | OLEMA PHARMACEUTICALS INC (US) | 2026-04-16 | — | — | US | disclosed |
| EP-0900218-A1 | HETEROCYCLIC COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-03-10 | — | — | EP | disclosed |
| EP-0497303-B1 | Carbamic acid derivatives and method for preparing the same | KYORIN SEIYAKU KK (JP) | 1998-05-27 | — | — | EP | disclosed |
| WO-1997040044-A1 | HETEROCYCLIC COMPOUNDS | ELI LILLY AND COMPANY (US) | 1997-10-30 | — | — | WO | disclosed |
| US-5300515-A | Cognition activators for brain disorders; alzheimer*s disease | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1994-04-05 | — | — | US | disclosed |
| CN-1064075-A | Carbamic acid derivative and preparation method thereof | ANZURIN PHARMACEUTICAL CO LTD (JP) | 1992-09-02 | — | — | CN | disclosed |
| EP-0497303-A2 | Carbamic acid derivatives and method for preparing the same | KYORIN PHARMACEUTICAL CO., LTD. (JP) | 1992-08-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103461-A1 | ESTROGEN RECEPTOR MODULATORS AND USES THEREOF | ESRRA, GPER1, ESR2 | MEN1 4532/4885ALDH1A1 1137/4885MAPT 4756/4885 |
| US-12630562-B2 | Piperidylurea compounds and methods of use thereof | CLIC1, HCCS, CNR1 | MEN1 2043/4885ALDH1A1 1002/4885MAPT 4783/4885 |
| US-12630528-B2 | Amino aryl derivative useful as diacylglycerol acyltransferase 2 inhibitor and use thereof | DGAT2, DGAT1, SOAT2 | MEN1 4788/4885ALDH1A1 597/4885MAPT 4476/4885 |
| US-12637440-B2 | Amide derivative useful as diacylglycerol acyltransferase 2 inhibitor, and use thereof | DGAT2, DGAT1, DLAT | MEN1 4822/4885ALDH1A1 885/4885MAPT 4369/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.